These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2073120)

  • 1. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.
    Koletar SL; Russell JA; Fass RJ; Plouffe JF
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2267-8. PubMed ID: 2073120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial.
    Yan Z; Liu X; Liu Y; Han Y; Lin M; Wang W; Guan X; Zhu S; Zhang H; Wang Q; Chou L; Zhu X; Hua H
    PLoS One; 2016; 11(12):e0167880. PubMed ID: 27977721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of fluconazole and clotrimazole in treatment of oral candidiasis.
    Madane PC; Choudary AS; Deepak TA; Abhinethra MS; Upasana L; Balaji R
    J Oral Maxillofac Pathol; 2022; 26(4):595. PubMed ID: 37082052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis.
    Rajadurai SG; Maharajan MK; Veettil SK; Gopinath D
    J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials.
    Almangour TA; Kaye KS; Alessa M; Eljaaly K; Sfouq Aleanizy F; Alsharidi A; Al Majid FM; Alotaibi NH; Alzeer AA; Alnezary FS; Alhifany AA
    Saudi Pharm J; 2021 Apr; 29(4):315-323. PubMed ID: 33994826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of essential oils from Iranian plants against fluconazole-resistant and fluconazole-susceptible Candida albicans.
    Sharifzadeh A; Shokri H
    Avicenna J Phytomed; 2016; 6(2):215-22. PubMed ID: 27222835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology, diagnosis and treatment of infectious esophagitis.
    Rosołowski M; Kierzkiewicz M
    Prz Gastroenterol; 2013; 8(6):333-7. PubMed ID: 24868280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.
    Vazquez JA
    HIV AIDS (Auckl); 2010; 2():89-101. PubMed ID: 22096388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis.
    Nairy HM; Charyulu NR; Shetty VA; Prabhakara P
    Trials; 2011 Apr; 12():99. PubMed ID: 21504616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD003940. PubMed ID: 21069679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.
    Vazquez JA
    Ther Clin Risk Manag; 2007 Aug; 3(4):533-42. PubMed ID: 18472974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential channels in sensory neurons are targets of the antimycotic agent clotrimazole.
    Meseguer V; Karashima Y; Talavera K; D'Hoedt D; Donovan-Rodríguez T; Viana F; Nilius B; Voets T
    J Neurosci; 2008 Jan; 28(3):576-86. PubMed ID: 18199759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.
    Fidel PL; Vazquez JA; Sobel JD
    Clin Microbiol Rev; 1999 Jan; 12(1):80-96. PubMed ID: 9880475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome.
    Wilcox CM; Mönkemüller KE
    Aliment Pharmacol Ther; 1997 Jun; 11(3):425-43. PubMed ID: 9218066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal agents in the 1990s. Current status and future developments.
    Kauffman CA; Carver PL
    Drugs; 1997 Apr; 53(4):539-49. PubMed ID: 9098658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?
    Graybill JR; Najvar LK; Holmberg JD; Correa A; Luther MF
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2197-200. PubMed ID: 8619566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.